Position in UTHR
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$9,070,776
-$2,887,258 QoQ
Shares Held
16,741
-17.0% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#189
of 874 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $43,567,425 across 30 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
56,839 | $9,579,645 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
16,741 | $9,070,776 | |
| 3 | ZTS |
Zoetis Inc.
|
66,412 | $4,772,366 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
167,856 | $2,690,731 | |
| 5 | VTRS |
Viatris Inc
|
160,652 | $2,551,153 | |
| 6 | HLN |
Haleon plc
|
259,261 | $2,418,905 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
70,403 | $2,385,253 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
74,362 | $1,830,048 |
All Filings in UTHR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,070,776 | 16,741 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $11,958,034 | 20,166 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,128,951 | 26,945 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $8,234,961 | 19,644 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,089,543 | 17,712 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,871,590 | 15,803 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,490,190 | 15,560 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,498,164 | 15,343 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,433,578 | 13,918 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,734,816 | 11,905 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,700,688 | 12,282 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $2,744,546 | 12,151 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,188,515 | 9,914 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,011,384 | 8,981 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,301,194 | 8,275 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,740,785 | 8,314 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,980,789 | 8,406 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,510,452 | 8,419 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,096,840 | 9,704 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,694,444 | 9,180 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,586,163 | 8,841 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,333,643 | 7,973 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $771,700 | 5,084 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $294,415 | 2,915 | Shares | Sole | 2020-12-10 | |
| 2020-06-30 | $327,063 | 2,703 | Shares | Sole | 2020-08-10 | |
| No filing history on record for this holder in this stock. | ||||||